John Craig Thompson's Net Worth

$2.61 Million

Estimate Recalculated Sep 9, 2024 12:23AM EST

Who is John Craig Thompson

John Craig Thompson has an estimated net worth of $2.61 Million. This is based on reported shares across multiple companies, which include TETRAPHASE PHARMACEUTICALS INC, Trius Therapeutics Inc, and Anthera Pharmaceuticals Inc.

SEC CIK

John Craig Thompson's CIK is 0001509643

Past Insider Trading and Trends

2015 was John Craig Thompson's most active year for acquiring shares with 7 total transactions. John Craig Thompson's most active month to acquire stocks was the month of December. 2015 was John Craig Thompson's most active year for disposing of shares, totalling 13 transactions. John Craig Thompson's most active month to dispose stocks was the month of August. 2015 saw John Craig Thompson paying a total of $1,336,610.55 for 192,499 shares, this is the most they've acquired in one year. In 2013 John Craig Thompson cashed out on 367,455 shares for a total of $3,084,250.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

TETRAPHASE PHARMACEUTICALS INC

Chief Operating Officer
Updated Sep 10, 2015
Form 4
-5.96%
-10.00K
$29.27
-$296.30K
Sep 10, 2015
157.84K
Sale
ScheduledSep 08
Form 4
-5.62%
-10.00K
$30.38
-$318.60K
Aug 07, 2015
167.84K
Sale
ScheduledAug 05
Form 4
-5.32%
-10.00K
$31.18
-$334.60K
Jul 08, 2015
177.84K
Sale
ScheduledJul 06
Form 4
-5.05%
-10.00K
$27.98
-$270.60K
Jun 16, 2015
187.84K
Sale
ScheduledJun 15
Form 4
-10.21%
-22.50K
$28.85
-$648.28K
Jun 10, 2015
197.84K
Sale
Jun 08
Form 4
-11.98%
-30.00K
$27.04
-$755.40K
May 19, 2015
220.34K
Sale
ScheduledMay 15
Form 4
100.00K
Jan 09, 2015
100.00K
Grant
Jan 07
Form 4
250.00K
Feb 05, 2014
250.00K
Grant
Feb 03
Form 3
Feb 05, 2014
Showing 9 results

Trius Therapeutics Inc

Chief Commercial Officer
Updated Sep 13, 2013
Form 4
-100.00%
-367.45K
$8.42
-$3.08M
Sep 13, 2013
Disposition
Sep 11
Form 4
125.00K
Mar 11, 2013
125.00K
Grant
Mar 07
Form 4
90.00K
Mar 12, 2012
90.00K
Grant
Mar 08
Form 4
133.00
$6.48
$861.84
Aug 24, 2011
133.00
Purchase
Aug 22
Form 4
150.00K
Jan 11, 2011
150.00K
Grant
Jan 10
Form 3
Jan 11, 2011
Showing 6 results

Anthera Pharmaceuticals Inc

President & CEO
Updated Sep 07, 2017
Form 4/A
1,158.13%
10.40K
$1.43
$14.89K
Sep 07, 2017
11.30K
Purchase
Sep 07
Form 4/A
200.00K
Mar 03, 2017
200.00K
Grant
Dec 06
Form 3
Jan 08, 2016
Showing 3 results